OR11I1P

Across TCGA pan-cancer cohorts, OR11I1P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated OR11I1P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR11I1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR11I1P expression acts as an unfavorable survival marker.

THCA, SKCM, and UVM are the cancer types where OR11I1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.685	0.936	<.001	90	view →
SKCM	OS	Tertile	All	0.545	0.787	.004	66	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	54	view →
GBM	OS	Tertile	All	0.079	0.422	<.001	27	view →
KIRC	DFS	Tertile	All	0.299	0.646	.006	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR11I1P–THCA (DFS)

Open the THCA breakdown →